Pharmacodynamic Modelling of Resistance to Epidermal Growth Factor Receptor Inhibition in Brain Metastasis Mouse Models

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-018-3630-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Epidermal Growth Factor Receptor Inhibition Strategies in Oncology

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2004English

Microtubule Inhibition Causes Epidermal Growth Factor Receptor Inactivation in Oesophageal Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2012English

Polo-Like Kinase 1 Inhibition Diminishes Acquired Resistance to Epidermal Growth Factor Receptor Inhibition in Non-Small Cell Lung Cancer With T790M Mutations

Oncotarget
Oncology
2016English

Protein Expression Signatures for Inhibition of Epidermal Growth Factor Receptor-Mediated Signaling

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2011English

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: The Evolving Role of Individualized Therapy

Cancer and Metastasis Reviews
Cancer ResearchOncology
2010English

Epidermal Growth Factor Receptor in Human Glioma

Journal of Neurosurgery
SurgeryNeurology
1989English

BRAF; Epidermal Growth Factor Receptor (EGFR)

Science-Business eXchange
2012English

Pertuzumab Increases Epidermal Growth Factor Receptor Down-Regulation by Counteracting Epidermal Growth Factor Receptor-ErbB2 Heterodimerization

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Expression of Epidermal Growth Factor Receptor in Patients With Insulin Resistance and Seborrheic Keratomas

Arkhiv Patologii
Forensic MedicinePathology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy